216 related articles for article (PubMed ID: 10861095)
1. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis.
Wang X; Chen M; Wandinger KP; Williams G; Dhib-Jalbut S
J Immunol; 2000 Jul; 165(1):548-57. PubMed ID: 10861095
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment.
Ozenci V; Kouwenhoven M; Huang YM; Xiao B; Kivisäkk P; Fredrikson S; Link H
Scand J Immunol; 1999 May; 49(5):554-61. PubMed ID: 10320650
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
[TBL] [Abstract][Full Text] [Related]
4. Impaired interleukin-12 production in multiple sclerosis patients.
Rohowsky-Kochan C; Molinaro D; Choudhry A; Kahn M; Cook SD
Mult Scler; 1999 Oct; 5(5):327-34. PubMed ID: 10516776
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of IL-12 by IFN-beta and IFN-gamma in human macrophages.
Jiang H; Dhib-Jalbut S
J Interferon Cytokine Res; 1998 Sep; 18(9):697-703. PubMed ID: 9781808
[TBL] [Abstract][Full Text] [Related]
6. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients.
Porrini AM; Gambi D; Reder AT
J Neuroimmunol; 1995 Aug; 61(1):27-34. PubMed ID: 7560009
[TBL] [Abstract][Full Text] [Related]
7. Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neuhaus O; Strasser-Fuchs S; Fazekas F; Kieseier BC; Niederwieser G; Hartung HP; Archelos JJ
Neurology; 2002 Oct; 59(7):990-7. PubMed ID: 12370451
[TBL] [Abstract][Full Text] [Related]
8. Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis.
Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
Clin Diagn Lab Immunol; 1996 Jul; 3(4):411-6. PubMed ID: 8807205
[TBL] [Abstract][Full Text] [Related]
9. A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.
Bakhiet M; Ozenci V; Withagen C; Mustafa M; Fredrikson S; Link H
Clin Diagn Lab Immunol; 1999 May; 6(3):415-9. PubMed ID: 10225846
[TBL] [Abstract][Full Text] [Related]
10. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.
Huang YM; Stoyanova N; Jin YP; Teleshova N; Hussien Y; Xiao BG; Fredrikson S; Link H
Clin Exp Immunol; 2001 May; 124(2):306-14. PubMed ID: 11422209
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta induces selective enhancement of antigen-specific T cell responses.
Pacocha SE; Oriente A; Lichtenstein LM; Huang SK; Essayan DM
J Interferon Cytokine Res; 2000 Apr; 20(4):383-9. PubMed ID: 10805373
[TBL] [Abstract][Full Text] [Related]
12. Effects of an anti-IL-10 monoclonal antibody on rIFNbeta-1b-mediated immune modulation. Relevance to multiple sclerosis.
Porrini AM; De Luca G; Gambi D; Reder AT
J Neuroimmunol; 1998 Jan; 81(1-2):109-15. PubMed ID: 9521612
[TBL] [Abstract][Full Text] [Related]
13. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients.
Jansson A; Ernerudh J; Kvarnström M; Ekerfelt C; Vrethem M
Mult Scler; 2003 Oct; 9(5):440-5. PubMed ID: 14582766
[TBL] [Abstract][Full Text] [Related]
14. Role of interferons in demyelinating diseases.
Arnason BG; Toscas A; Dayal A; Qu Z; Noronha A
J Neural Transm Suppl; 1997; 49():117-23. PubMed ID: 9266421
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS.
Chabot S; Yong VW
Neurology; 2000 Nov; 55(10):1497-505. PubMed ID: 11094104
[TBL] [Abstract][Full Text] [Related]
16. Interferon beta induces T-helper 2 immune deviation in MS.
Kozovska ME; Hong J; Zang YC; Li S; Rivera VM; Killian JM; Zhang JZ
Neurology; 1999 Nov; 53(8):1692-7. PubMed ID: 10563614
[TBL] [Abstract][Full Text] [Related]
17. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis.
Byskosh PV; Reder AT
Mult Scler; 1996 Apr; 1(5):262-9. PubMed ID: 9345428
[TBL] [Abstract][Full Text] [Related]
18. T-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients.
Bongioanni P; Lombardo F; Moscato G; Mosti S; Meucci G
Eur J Neurol; 2000 Nov; 7(6):647-53. PubMed ID: 11136350
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA
J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
D'Andrea A; Aste-Amezaga M; Valiante NM; Ma X; Kubin M; Trinchieri G
J Exp Med; 1993 Sep; 178(3):1041-8. PubMed ID: 8102388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
